Dear Colleagues-
The National Institute on Drug Abuse (NIDA) invites your feedback on the draft NIDA Racial Equity Initiative Action Plan. Our ongoing Racial Equity Initiative has been spearheading the Institute’s efforts to address the impact of structural racism on addiction science and to take action to promote racial equity in NIDA’s workplace, workforce, and research portfolio.
Your comments are welcome on all areas of the plan. Please also feel free to share the RFI widely to encourage as broad a response as possible. Responses are due by May 31, 2022.
For additional information, including a link to the action plan and instructions for submitting feedback, please visit: https://grants.nih.gov/grants/guide/notice-files/NOT-DA-22-052.html
A blog post on this effort from Nora can be found here: https://nida.nih.gov/about-nida/noras-blog/2022/03/plan-to-address-racism-in-addiction-science
Help NIDA spread the word:
· Twitter: http://twitter.com/NIDAnews/status/1508474854261014536
· Facebook: https://www.facebook.com/338746364953505
· LinkedIn: https://www.linkedin.com/feed/update/urn:li:share:6914241480714817536/
We look forward to hearing from you!
Will M. Aklin and Emily Einstein, NIDA Racial Equity Initiative co-leads”
Emily B. Einstein, PhD
Chief, Science Policy Branch
Office of Science Policy and Communications
National Institute on Drug Abuse
Will M. Aklin, Ph.D.
Director, Behavioral Therapy Development Program (BTDP)
Clinical Research Grants Branch
Division of Therapeutics and Medical Consequences (DTMC)
National Institute on Drug Abuse
-----------
The National Institute on Drug Abuse at the National Institutes of Health is an agency of the United States Department of Health and Human Services TO UNSUBSCRIBE: send email to listserv@list.nih.gov Copy and paste UNSUBSCRIBE NIDA_NEURO_SCIENCE-L
No comments:
Post a Comment